Selective Institutional Bets Emerge in Medical and Tech NichesGlobal Report·Oct 21, 2026 at 10:15 AMBSL+0.08%BSEM+2.44%
Supernus Pharmaceuticals Holds Special Stockholder MeetingPUBT·Oct 15, 2026 at 08:12 PMINDV+0.06%SUPN-0.05%
Indivior to rename as Supernus after merger; supplemental proxy discloses Cantor valuation rangesTradingView·Oct 6, 2026 at 11:23 AMINDV+0.06%SUPN-0.05%
Indivior Pharmaceuticals announces special shareholder meeting on merger with SupernusPUBT·Oct 6, 2026 at 11:16 AMINDV+0.06%SUPN-0.05%
Are LFCR, ITGR, FHB, INDV Obtaining Fair Deals for their Shareholders?prnewswire·Sep 29, 2026 at 05:53 PMFHB-0.24%INDV+0.06%
ACT NOW - The M&A Class Action Firm Is Investigating the Merger -- FHB, INDV, ITGR, and LNTHprnewswire·Sep 28, 2026 at 11:23 PMFHB-0.24%INDV+0.06%
Addex Therapeutics Reports 2026 Half-Year Results and Provides Corporate UpdateGlobeNewswire·Sep 28, 2026 at 05:00 AMADXN-1.97%INDV+0.06%
Addex Therapeutics shares are trading higher after the company announced it regained full global rights to all GABAB positive allosteric modulator assets discovered under its research collaboration with Indivior UK.benzinga_article·Sep 25, 2026 at 12:28 PMADXN-1.97%INDV+0.06%
Are ITGR, BZH, SUPN Obtaining Fair Deals for their Shareholders?prnewswire·Sep 25, 2026 at 11:40 AMSUPN-0.05%ITGR0.00%
Addex regains global rights to GABAB PAM assets from IndiviorPUBT·Sep 25, 2026 at 05:00 AMADXN-1.97%INDV+0.06%
Indivior Announces Special Dividend Ahead of Supernus MergerTip Ranks·Sep 17, 2026 at 11:47 AMINDV+0.06%SUPN-0.05%
Indivior sets USD 8.13 special dividend tied to Supernus merger closingPUBT·Sep 17, 2026 at 11:01 AMINDV+0.06%SUPN-0.05%
SUPN Stock Alert: Halper Sadeh LLC is Investigating Whether Supernus Pharmaceuticals, Inc. is Obtaining a Fair Price for its ShareholdersMorningStar·Aug 29, 2026 at 11:32 AMSUPN-0.05%INDV+0.06%
Top Indivior Insider Quietly Ramps Up Stake in Bold New MoveTip Ranks·Aug 28, 2026 at 02:08 AMINDV+0.06%SUPN-0.05%
